Short Summary
The USPTO denied Cisco and Fortinet's request for Director review of a prior institution denial in IPR2024-00540, leaving the original decision unchanged.
Detailed Summary
In IPR2024-00540 concerning U.S. Patent 8,347,350, Cisco Systems and Fortinet petitioned for Director review of the USPTO's earlier decision to deny institution of an inter partes review against InfoExpress. Director Katherine K. Vidal recused herself, and Deputy Under Secretary Derrick Brent evaluated the request. The Director ultimately denied the review, affirming the original institution denial and concluding the petitioners' attempt to revive the IPR.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in CISCO SYSTEMS, INC. et al. vs InfoExpress Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Arista Networks, Inc.vsOrckit Corporation
Arista Networks has filed a petition challenging U.S. Patent No. 7,545,740 held by Orckit Corporation, asserting obviousness under 35 U.S.C. § 103. The petitioner argues that the claimed bi-directional link aggregation and hash-based selection mechanisms were already known in prior art references like Bruckman, Basso, and Holdsworth. This challenge targets core networking technology used for load balancing.
BTL Industries, Inc.vsInMode Ltd.
ThermiGen settled its patent infringement lawsuit with Viveve Medical, securing a non‑exclusive license and agreeing to pay royalties. The settlement resolves the 2016 litigation and allows Thermi to continue developing its temperature‑controlled RF platforms for women's intimate health.
smaXtec Inc. et al.vsST Reproductive Technologies, LLC
The PTAB found several claims of the '644 patent unpatentable based on anticipation (35 U.S.C. § 102) and obviousness (35 U.S.C. § 103). The Board concluded that prior art references, specifically Harvey and Riskey, disclosed all elements of key claims related to animal monitoring bolus sensors.
Trove Brands, LLCvsCamelBak Products, LLC
Trove Brands has filed an IPR petition seeking cancellation of 16 claims of CamelBak’s 11,684,187 patent covering drink containers with removable caps. The petition relies on prior art from Kiyota, Choi, Park, and Ribarits to argue obviousness and asserts a means‑plus‑function construction for the “user release mechanism.”
CrowdStrike, Inc. et al.vsGoSecure, Inc.
GoSecure seeks Director Review to vacate the institution of two IPRs filed by CrowdStrike that challenge all 21 claims of U.S. Patent 9,954,872. The patent owner alleges the Board abused discretion by allowing duplicate petitions, misapplying claim ambiguity, and incorrectly construing “computer system.”
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.